STELLA PHARMA CORPORATION (4888.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 434.00

From 52W high−51.08%

Volume442700.00

Market capJPY 14.66B

P/E (TTM)—

P/S (TTM)45.3x

Div yield—

Key dataSep 18, 2026

Open

JPY 434.00

From 52W high

−51.08%

Volume

442700.00

Market cap

JPY 14.66B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−14.1x

P/E (TTM)

—

RSI (14)

71.6

MomentumView details →

1D Return

+4.36%

YTD Return

+108.87%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−14.1x

EV/Sales

36.4x

P/S (TTM)

45.3x

P/B (TTM)

4.6x

ProfitabilityView details →

Gross Margin

86.43%

Net Margin

−241.49%

EBITDA Margin

−222.72%

ROE (TTM)

−32.15%

ROA (TTM)

−17.39%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

−66.39%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+12.15%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+4.36%

YTD Return

+108.87%

1Y Return

+21.14%

RSI (14)

71.6

vs 50D SMA

+23.00%

vs 200D SMA

+9.37%

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

16.75x

Quick Ratio

12.10x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

323.00M

Net Income (TTM)

−780.00M

Op. CF (TTM)

—

Next earningsNov 5, 2026 →

Latest newsMore news →

Stella Pharma announced a third-party allotment of 1 million shares to CVI Investments at an issue price of 299 yen per share.38d ago

China Bio-Pharmaceutical Services signed a master cooperation agreement with Stella Pharma to jointly develop and commercialize Steboronine, the world's first approved boron neutron capture therapy drug, in China.40d ago

Similar companies

Renascience Inc.4889.T CanBas Co.,Ltd.4575.T RaQualia Pharma Inc.4579.T TAIKO PHARMACEUTICAL CO.,LTD.4574.T AnGes,Inc.4563.T MediciNova,Inc.4875.T Find similar companies →

Latest newsMore news →

Stella Pharma announced a third-party allotment of 1 million shares to CVI Investments at an issue price of 299 yen per share.38d ago China Bio-Pharmaceutical Services signed a master cooperation agreement with Stella Pharma to jointly develop and commercialize Steboronine, the world's first approved boron neutron capture therapy drug, in China.40d ago